These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37484708)

  • 21. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
    Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy.
    Takata K; Honda S; Sidharta SL; Duong M; Shishikura D; Kim SW; Andrews J; Di Bartolo BA; Psaltis PJ; Bursill CA; Worthley MI; Nicholls SJ
    Cardiovasc Diagn Ther; 2019 Aug; 9(4):310-318. PubMed ID: 31555535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment.
    Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ
    Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis.
    Tejera-Segura B; Macía-Díaz M; Machado JD; de Vera-González A; García-Dopico JA; Olmos JM; Hernández JL; Díaz-González F; González-Gay MA; Ferraz-Amaro I
    Arthritis Res Ther; 2017 May; 19(1):113. PubMed ID: 28569219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Density Lipoprotein Function Is Reduced in Patients Affected by Genetic or Idiopathic Hypogonadism.
    Adorni MP; Zimetti F; Cangiano B; Vezzoli V; Bernini F; Caruso D; Corsini A; Sirtori CR; Cariboni A; Bonomi M; Ruscica M
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3097-3107. PubMed ID: 30835274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma.
    Adorni MP; Biolo M; Zimetti F; Palumbo M; Ronda N; Scarinzi P; Simioni P; Lupo MG; Ferri N; Previato L; Bernini F; Zambon A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritionally Derived Metabolic Cues Typical of the Obese Microenvironment Increase Cholesterol Efflux Capacity of Adipose Tissue Macrophages.
    O'Reilly ME; Kajani S; Ralston JC; Lenighan YM; Roche HM; McGillicuddy FC
    Mol Nutr Food Res; 2019 Jan; 63(2):e1800713. PubMed ID: 30411491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I.
    Gelissen IC; Harris M; Rye KA; Quinn C; Brown AJ; Kockx M; Cartland S; Packianathan M; Kritharides L; Jessup W
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):534-40. PubMed ID: 16357317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus.
    Ronda N; Favari E; Borghi MO; Ingegnoli F; Gerosa M; Chighizola C; Zimetti F; Adorni MP; Bernini F; Meroni PL
    Ann Rheum Dis; 2014 Mar; 73(3):609-15. PubMed ID: 23562986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis.
    Salahuddin T; Natarajan B; Playford MP; Joshi AA; Teague H; Masmoudi Y; Selwaness M; Chen MY; Bluemke DA; Mehta NN
    Eur Heart J; 2015 Oct; 36(39):2662-5. PubMed ID: 26188212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients.
    Ferraz-Amaro I; Hernández-Hernández MV; Armas-González E; Sánchez-Pérez H; Machado JD; Díaz-González F
    Clin Rheumatol; 2020 Jun; 39(6):1871-1880. PubMed ID: 31993889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects.
    Favari E; Ronda N; Adorni MP; Zimetti F; Salvi P; Manfredini M; Bernini F; Borghi C; Cicero AF
    J Lipid Res; 2013 Jan; 54(1):238-43. PubMed ID: 23103472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation.
    Minami-Takano A; Iwata H; Miyosawa K; Shiozawa T; Hayashi H; Funamizu T; Ishii K; Nozaki Y; Tabuchi H; Sekita G; Shimada K; Sumiyoshi M; Nakazato Y; Daida H; Minamino T
    Sci Rep; 2021 Feb; 11(1):3547. PubMed ID: 33574408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.
    Greco D; Kocyigit D; Adorni MP; Marchi C; Ronda N; Bernini F; Gurses KM; Canpinar H; Guc D; Oguz SH; Gurlek A; Strazzella A; Simonelli S; Tokgozoglu L; Zimetti F
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):822-829. PubMed ID: 29954641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
    El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein oxidation may underlie the paradoxical association of low cholesterol with coronary atherosclerotic risk in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; Ronda N; Hernandez E; Budoff MJ
    J Autoimmun; 2022 May; 129():102815. PubMed ID: 35366608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
    Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
    J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.